Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion type Assertion NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_head.
- NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion wasGeneratedBy ECO_0000203 NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_provenance.
- NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion wasDerivedFrom befree-20150227 NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_provenance.
- NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion SIO_000772 22261808 NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_provenance.
- NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion evidence source_evidence_literature NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_provenance.
- NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_provenance.